Estate Planners Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-181
Closed -$5.24K – 104
2025
Q4
$5.24K Buy
+181
New +$5.43K ﹤0.01% 333

Other funds holding ARKG

Estate Planners Group's ARKG Position: Q1 2026 in Review

Estate Planners Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 181 shares — an estimated $5.24K sold.

Estate Planners Group first reported a position in ARKG in Q4 2025 and held it in 1 quarter. The position peaked at $5.24K in Q4 2025. 220 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Estate Planners Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Estate Planners Group sold 181 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $5.24K.
  • Estate Planners Group first reported a position in ARK Genomic Revolution ETF in Q4 2025 and held it in 1 quarter.
  • Estate Planners Group's ARK Genomic Revolution ETF position peaked at $5.24K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.